logo
Select company
Select metric
$ 8.8MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
22
Sector
40
Industry
51
History
-
$ 1.21Close
$ 0.45 - $ 2.21 52-Week Range
Ticker Information

Ticker

KAPA

Company Name

KAIROS PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

KAIROS PHARMA LTD - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KAPA - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 8.8M
3/31/2025$ 8.58M
12/31/2024$ 5.52M
9/30/2024$ 5.52M
12/31/2023$ 0
12/31/2022$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KAIROS PHARMA LTD's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, KAIROS PHARMA LTD's average CF - Equity has been $ 4.74M.
  • The median CF - Equity for KAIROS PHARMA LTD during this period was $ 5.52M
  • KAIROS PHARMA LTD reached its highest CF - Equity over the past 5 years at $ 8.8M.
  • The lowest CF - Equity recorded by KAIROS PHARMA LTD in the same timeframe $ 0

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

KAPA - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Dec 31, 2022

$ 8.8M

Maximum

Jun 30, 2025

$ 4.74M

Average

$ 5.52M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M